Viewing nowK-cept Tablets 10 mg (Donepezil Hydrochloride Hydrate)
Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

MFDS item code 200605537 · Notified 2006.06.22 · Insurance code 671701150
Treatment of symptoms of Alzheimer-type dementia
This medication is used for the treatment of symptoms of Alzheimer's type dementia.
○ Adults: Donepezil hydrochloride should be administered at a dose of 5 mg once daily at bedtime. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, administration of this drug in the morning may be considered. Since donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, the 5 mg dose should be administered for 4~6 weeks. After assessing the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. When administration of this drug is discontinued, its effects gradually diminish, and no rebound effect occurs with abrupt discontinuation. ○ Female patients aged 85 years or older with low body weight: Careful monitoring is required because adverse reactions occur more frequently. Elderly women with low body weight should not exceed 5 mg daily.
○ Pediatric patients: There is no experience with use in pediatric patients.
This medication contains Donepezil Hydrochloride Hydrate as its main ingredient and is primarily used to improve symptoms of Alzheimer's type dementia. First, this medication should not be administered to certain patients. For example, individuals who have an allergy to this medication or its ingredients, pregnant women or those who may become pregnant, and nursing women should not take this medication. Additionally, because it contains lactose, individuals with lactose intolerance or specific genetic lactose metabolism disorders should not use this medication. When using this medication, certain health conditions should be carefully monitored. Patients with heart diseases, particularly those at risk of bradycardia or arrhythmia, should have their heart function closely observed. Additionally, patients with a history of peptic ulcers or those taking non-steroidal anti-inflammatory drugs should closely monitor their gastrointestinal condition. Patients with asthma or obstructive lung diseases may experience exacerbation of symptoms when taking this medication, thus caution is needed. Patients with extrapyramidal disorders such as Parkinson's disease may also see worsening of symptoms with this medication. Various side effects have been reported with this medication. Cardiac-related problems may include fainting, bradycardia, heart block, and heart failure, while gastrointestinal issues may lead to gastric ulcers, gastrointestinal bleeding, nausea, vomiting, and diarrhea. Serious adverse reactions have also been reported including liver dysfunction, cerebrovascular problems, seizures, movement disorders, respiratory distress, acute pancreatitis, and acute renal failure. Additionally, a variety of neurological and skin responses such as hallucinations, insomnia, anxiety, depression, myalgia, rashes, and others may also occur. Since this medication may affect cardiac conduction, ECG monitoring is necessary when taken with medications that carry the risk of QT interval prolongation or ventricular tachycardia. It may also interact with several drugs, particularly those that inhibit or induce the enzymes that metabolize this medication in the liver, thus caution should be exercised. Pregnant or nursing women should avoid using this medication, and if absolutely necessary, it should be done in consultation with healthcare professionals. Safety in children has not yet been established. In cases of overdose, symptoms may include nausea, vomiting, bradycardia, respiratory depression, and seizures, requiring urgent treatment. In such cases, antidotes like atropine may be used for treatment. Finally, this medication should be stored out of the reach of children and should not be transferred to other containers as this may affect product quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture ingress, ideally at room temperature between 1 to 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be maintained for a longer period.
Yellow round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.